Interstitial Lung Disease management across Germany: A nationwide, cross-sectional survey among pulmonologists and rheumatologists to evaluate possible differences in regional and intersectoral care (CareILD)

Study identification

• EU PAS number:
  EUPAS1000000871
• Study ID:
  1000000871
• Official title and acronym:
  Interstitial Lung Disease management across Germany: A nationwide, cross-sectional survey among pulmonologists and rheumatologists to evaluate possible differences in regional and intersectoral care (CareILD)
• DARWIN EU® study:
  No
• Study countries:
  Germany
• Study description:
  CareILD is a non-interventional, cross-sectional survey collecting self-reported data from pulmonologists and rheumatologists involved in ILD management in Germany. Data will be obtained via a one-time online questionnaire with both closed- and open-ended items, enabling quantitative and qualitative analysis. No individual patient data will be collected.
• Study status:
  Planned

Research institutions and networks

Institutions

Boehringer Ingelheim

Study timelines

Date when funding contract was signed

Planned:24/06/2025

Actual:24/06/2025

Study start date

Planned:19/01/2026

Data analysis start date

Planned:15/04/2026

Date of final study report

Planned:31/08/2026

Regulatory

• Was the study required by a regulatory body?:
  No
• Is the study required by a Risk Management Plan (RMP)?:
  Not applicable